Keloid scar zinc hyaluronate excision keloid
Conditions
Interventions
Zinc hyaluronate in gel (therapeutic agent) was injected intralesional after excision keloid scar and primary sutured wound. ,Sterile gel (therapeutic agent) was injected intralesional after excisio
Experimental Procedure/Surgery,Placebo Comparator Procedure/Surgery
Zinc hyaluronate,Sterile gel
Sponsors
Faculty of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Keloid patients who were presumed to undergo surgical excision and primary closure because of a diagnosis of a keloid scar anywhere on the body were enrolled.
Exclusion criteria
Exclusion criteria: Patients were excluded before randomization if they met the following criteria: receipt of other treatments such as intralesional steroid injection, silicone sheet, or radiation for the keloid less than 3 months before enrollment; a history of triamcinolone acetonide hypersensitivity or anaphylaxis, immunocompromised patients, patients using steroid or immunosuppressive drugs, and patients who refused to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrent keloid scar 5 years wound size (length, width, and height) based on a physical examination | — |
Secondary
| Measure | Time frame |
|---|---|
| safety 5 years adverse events | — |
Countries
Thailand
Contacts
Public ContactSakchai Ruangsin
Faculty of Medicine, Prince of Songkla University
Outcome results
None listed